Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always
- PMID: 36331161
- PMCID: PMC10321306
- DOI: 10.1002/ana.26542
Neocortical Lewy Body Pathology Parallels Parkinson's Dementia, but Not Always
Abstract
Objective: The objective of this study was to evaluate the relationship between Parkinson's disease (PD) with dementia and cortical proteinopathies in a large population of pathologically confirmed patients with PD.
Methods: We reviewed clinical data from all patients with autopsy data seen in the Movement Disorders Center at Washington University, St. Louis, between 1996 and 2019. All patients with a diagnosis of PD based on neuropathology were included. We used logistic regression and multivariate analysis of covariance (MANCOVA) to investigate the relationship between neuropathology and dementia.
Results: A total of 165 patients with PD met inclusion criteria. Among these, 128 had clinical dementia. Those with dementia had greater mean ages of motor onset and death but equivalent mean disease duration. The delay between motor symptom onset and dementia was 1 year or less in 14 individuals, meeting research diagnostic criteria for possible or probable dementia with Lewy bodies (DLB). Braak Lewy body stage was associated with diagnosis of dementia, whereas severities of Alzheimer's disease neuropathologic change (ADNC) and small vessel pathology did not. Pathology of individuals diagnosed with DLB did not differ significantly from that of other patients with PD with dementia. Six percent of individuals with PD and dementia did not have neocortical Lewy bodies; and 68% of the individuals with PD but without dementia did have neocortical Lewy bodies.
Interpretation: Neocortical Lewy bodies almost always accompany dementia in PD; however, they also appear in most PD patients without dementia. In some cases, dementia may occur in patients with PD without neocortical Lewy bodies, ADNC, or small vessel disease. Thus, other factors not directly related to these classic neuropathologic features may contribute to PD dementia. ANN NEUROL 2023;93:184-195.
© 2022 American Neurological Association.
Conflict of interest statement
POTENTIAL CONFLICTS OF INTEREST
None
Figures


Comment in
-
Reply to "Concomitant Alzheimer's Disease Pathology in Parkinson's Disease Dementia".Ann Neurol. 2023 May;93(5):1046-1047. doi: 10.1002/ana.26630. Epub 2023 Mar 20. Ann Neurol. 2023. PMID: 36891825 No abstract available.
-
Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia.Ann Neurol. 2023 May;93(5):1045-1046. doi: 10.1002/ana.26635. Epub 2023 Mar 16. Ann Neurol. 2023. PMID: 36892304 Free PMC article. No abstract available.
References
-
- Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24:197–211 - PubMed
-
- Aarsland D, Zaccai J & Brayne C A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 2005;20:1255–1263 - PubMed
-
- Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7:47. - PubMed
-
- Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837–844 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous